This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News. In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.
Multiple stakeholders are to blame for prescription drug costs, including pharmaceutical companies and PBMs, according to Merith Basey, executive director of Patients for Affordable Drugs. The post Who Is Responsible for the High Cost of Prescription Drugs? One Advocate Weighs In appeared first on MedCity News.
QUICK READ: A two-month analysis of social media and prescription drugs found the number one reason online health seekers use social media is to share and ask questions about medication side effects. ” – Patients were sharing experiences of switching to, or starting, prescription drugs.
If you thought that Big Pharma and the PBMs were the only bad guys in the saga of unreasonably high prescription drug prices in the United States, you would be wrong. The post Video: Besides, Pharma and PBMs, Who Drives Up Drug Costs? Hear who else is to blame from the CEO of Blue Shield of California.
For many, these coupons represent the difference between filling a prescription and going without lifesaving care, but there is a lot more here than just a co-pay coupon. Pharma companies have very little control over patients’ prices for their Rxs. Let’s take a step back for a minute.
s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. s drug pricing policy, the pharma industry has secured an improved government spending deal. After blasting the U.K.’s After blasting the U.K.’s
The FDA approved RiVive, an over-the-counter version of naloxone nasal spray from Harm Reduction Therapeutics. It’s the second such approval from the FDA this year, following an affirmative decision in March for OTC Narcan.
Doctors, 99% of whom were acting in good faith, determined the total volume of prescription opioids that pharmacies ordered from defendants and dispensed pursuant to those prescriptions,” Faber wrote in his opinion. The post Misjustice benefits pharma appeared first on World of DTC Marketing.com.
Just 13% of people trust the pharma companies they interact with. If pharma is going to leap to a new era of marketing, they have to get to know their audiences. Some believe that these behaviors won’t translate to prescription drugs, but that would be a mistake. The post A new era of pharma marketing?
IN BRIEF: Pharma companies have been posting jobs on LinkedIn almost every day. While most offices remain closed pharma is preparing for the launch of new products and has to have the infrastructure to ensure a successful launch. This is a great time for people who want to be the change they want to see to work in pharma.
Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. The hottest pharma product is Lilly’s diabetes drug, hyped by the media as helping patients lose weight. The post Uniqueness if pharma DTC. appeared first on World of DTC Marketing.com.
Unlike consumer brands that can use aggressive bidding strategies on high-volume keywords, pharma ads must navigate strict regulatory guidelines. For an in-depth look at how pharma companies succeed in digital advertising, visit Pharma Marketing Network. Understanding Pharma-Specific PPC Challenges 1.
Pharma has an opportunity to engage customers and caregivers via email but they can’t send out product flyers. Pharma has unique needs for email automation which is why any email automation has to meet MLR requirements. The other challenge for pharma in an email marketing campaign is privacy.
Tik-Tok, Instagram, and other social media channels may soon be overwhelmed with pharma companies’ content, but is it a good idea? Pharma companies have policies that heavily restrict their use of social media and limit their ability to benefit from the wealth of data that could accompany it. What about social media options?
Medication adherence is a large and growing challenge for pharma companies, healthcare providers and the patients they serve. In the U.S. Research shows that 20% of patients have failed to fill a script in the past, and one-third aren’t confident managing their illness. Engaging patients from the moment a drug is prescribed can help.
SUMMARY: The biggest argument against pharma is the cost of prescription drugs. Pharma could do something about this by simply uniting to make it easier for patients who can’t afford their medications to get them free or at little cost.
As people move up the pharma ladder, their work often revolves around internal management issues, training, and endless meetings to motivate their employees rather than focus on patients. Pharma likes to believe its own propaganda that everything they do is patient-focused, but that’s a canard.
(Endpoints) Pharma TV advertising boomed in 2021 – to the tune of $3.91 billion across prescription meds, iSpot reports. year over year, which may not sound like much but marks pharma’s steady growth through the pandemic. The post Pharma spent $3.9B That’s an increase of 4.8% What a waste of money.
And Pfizer said “no” The government is the largest purchaser of prescription drugs, and they should be allowed to negotiate prices with pharma companies whose profit margins are the highest of any industry. The post The hypocrisy of big pharma. Remember when J&J asked for help from Pfizer on their vaccine?
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), provides a peek into what the association has set out to accomplish.
Can pharma leverage influencer marketing? People are turning to their favorite Instagram stars, Twitter personalities, and YouTubers for advice and recommendations on purchasing decisions, but does this apply to prescription drugs? Influencers have already been talking about pharma. The post Influencer marketing in pharma.
It’s hard to justify those price increases, but pharma is big business, as all parties in healthcare are. Many people I talk with acknowledge that pharma has been profiteering from drug sales, but they balance that with the need for new drugs to help patients live a better quality of life. million people have died.
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. But how can pharma marketers break through the noise, engage their audience, and see real ROI? Drive prescription intent by educating HCPs about the latest drug advancements.
With strict regulations, increasing competition, and evolving ad platform policies, running a successful PPC campaign in pharma isnt as straightforward as in other industries. So, how can pharma brands ensure their Google Ads, LinkedIn campaigns, and paid social media ads are effective? diabetes, cancer).
Numerous clinical, regulatory and financial factors are behind this digital shift in pharma. And in the first quarter of this year, the largest Series A ever in digital health ($203M) went into a company accelerating clinical trials and drug development.
In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. It should be a warning to other pharma companies. Now Biogen is a shell of a company selling off assets to survive.
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. So, how can pharma marketing teams maximize the impact of their Google Ads while staying compliant?
Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives.
SUMMARY: The biggest threat to the pharma industry isn’t the coming tsunami of healthcare changes. ” All over pharma DTC, people and agencies are coming to senior pharma managers with great, patient-driven ideas. To a lot of pharma marketing people, everything they do is about generating business.
SUMMARY: “How big pharma takeovers destroy innovation” a report from Congresswoman Porter does make some points. I always have pointed instances in which pharma puts Wall Street first and patients second. I have worked with and stayed in contact with some R&D people within pharma and they have a different answer.
Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices. Big Pharma’s chokehold around the U.S. Via Axios “The 10 highest-selling drugs in the U.S.
SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 2wo: DTC marketing is one of the reasons prescription drugs cost so much. DTC ads raise awareness around health conditions.
Now all Zócalo patients have access to Cost Plus Drugs’ prescriptions, and the provider’s community health workers have been trained to help walk patients through the process of obtaining medications through the pharmacy.
Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. The headline and byline in a Times editorial said it all “Don’t Fall for Big Pharma’s Savior Act, Heroic work went into the development of the coronavirus vaccines.
We can apply this approach in pharma by enhancing our patient journey maps and go beyond focusing on the key clinical engagement touch points (e.g., doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events.
I continue to believe that there are very good people who care about patients working within pharma but it’s hard to understand how anyone who works for AbbVie can feel good about their employer. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S.
Introduction Pharma marketing is constantly evolving, with new digital tools, regulatory updates, and data-driven strategies shaping the industry. How do pharma marketing executives ensure they are using the best tools and strategies? However, with so much information available, finding the right resources can feel overwhelming.
Narcan, a nasal spray product that reverses the effects of opioid overdose, is now FDA approved for non-prescription use. Other recent FDA approvals include decisions for drugs from Pharming Group, Incyte, and Aurion Biotech.
Artificial intelligence is revolutionizing how pharma brands engage with healthcare professionals (HCPs) and patients, optimizing advertising campaigns, and improving customer experiences. As competition in the healthcare space intensifies, pharma brands that fail to integrate AI risk falling behind.
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. Nowhere is this clearer than in pharma DTC TV ads. A Prevention Magazine study dated had prescription DTC ads as being 7% effective in driving new Rx’s. ” Ninety-two percent of U.S.
Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster? Key pillars include: 1.
SUMMARY: Today, more physicians and patients rely on the Internet to answer their questions about emerging treatments, including prescription drugs. If there is one industry that needs to think more about digital, it’s pharma. This is a severe concern in an era where more HCPs are refusing to meet with pharma reps.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content